Progressive multi‐focal leucoencephalopathy – driven from rarity to clinical mainstream by iatrogenic immunodeficiency

Summary Advances in immune‐mediated targeted therapies have proved to be a double‐edged sword for patients by highlighting the risk of iatrogenic infective complications. This has been exemplified by progressive multi‐focal leucoencephalopathy (PML), a hitherto rare devastating viral infection of th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and experimental immunology 2017-06, Vol.188 (3), p.342-352
1. Verfasser:	Misbah, S. A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal - therapeutic use Brain - virology cell trafficking Disease Management EAE/MS Humans Iatrogenic Disease - epidemiology immunodeficiency diseases Immunosuppression Therapy - adverse effects Immunosuppressive Agents - therapeutic use JC Virus Leukoencephalopathy, Progressive Multifocal - diagnosis Leukoencephalopathy, Progressive Multifocal - epidemiology Leukoencephalopathy, Progressive Multifocal - therapy neuroimmunology Polyomavirus Infections - epidemiology Review viral
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!